Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Employees

1,399

Sector

Pharmaceuticals

Calendar

09-04 Ex-dividend date - 4 INR

More about the company

Quotes

Date	Price	Change	Volume
27/08/26	₹236.99	-2.15%	66,137
26/08/26	₹242.20	+0.32%	76,102
25/08/26	₹241.43	+0.27%	44,621
24/08/26	₹240.77	+1.79%	219,001
21/08/26	₹236.54	+1.52%	92,791

Delayed Quote NSE India S.E.

More quotes

Market Closed - NSE India S.E. 15:05:08 27/08/2026 +04			5-day change	1st Jan Change
236.99 ^INR	-2.15%		+2.91%	+23.04%

07-30	Jagsonpal Pharmaceuticals Limited announces Annual dividend, payable on October 18, 2026	CI
07-29	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Market Cap	12.32B 129M 111M 104M 94.95M 179M 179M 1.23B 480M 6.21B 484M 474M 20.56B	P/E 2024	32.7x	P/E 2025	26.4x
Enterprise Value	11.13B 117M 100M 93.64M 85.74M 162M 162M 1.11B 433M 5.61B 437M 428M 18.56B	EV / Sales 2024	2.84x	EV / Sales 2025	4.92x
Free-Float	23.94%	Yield 2024	1.81%	Yield 2025	1.15%

07-30	Jagsonpal Pharmaceuticals Limited announces Annual dividend, payable on October 18, 2026	CI
07-29	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-17	Jagsonpal Pharmaceuticals Limited completed the acquisition of 85% stake in Aequitas Healthcare Private Limited.	CI
06-29	Jagsonpal Pharmaceuticals Limited entered into a definitive agreement to acquire 85% stake in Aequitas Healthcare Private Limited for approximately INR 210 million.	CI
05-25	Tranche Update on Jagsonpal Pharmaceuticals Limited's Equity Buyback Plan announced on March 12, 2026.	CI
05-18	Jagsonpal Pharmaceuticals Limited Announces Resignation of Pallavi Dinodia Gupta as the Independent Director, Effective May 18, 2026	CI
05-14	Jagsonpal Pharmaceuticals Limited's Equity Buyback announced on March 12, 2026, has closed with 1,600,000 shares, representing 2.44% for INR 400 million.	CI
05-07	Jagsonpal Pharmaceuticals Sets Dates for INR400 Million Buyback	MT
04-28	Jagsonpal Pharmaceuticals Net Profit Jumps in Fiscal Q4	MT
04-27	Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2026	CI
04-27	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-27	Jagsonpal Pharmaceuticals passes buy-back resolution	RE
03-13	Jagsonpal Pharmaceuticals gets order for tax demand of 48.2 million rupees	RE

30/08/22	Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme	PU
16/08/22	Jagsonpal Pharmaceuticals : Reply to Clarification Sought	PU
16/07/22	Jagsonpal Pharmaceuticals : Appointment	PU

Jagsonpal Pharmaceuticals Limited Stock

Stocks

JAGSNPHARM

INE048B01035

Pharmaceuticals

Valuation : Jagsonpal Pharmaceuticals Limited

Chart: Jagsonpal Pharmaceuticals Limited

Latest news : Jagsonpal Pharmaceuticals Limited

Press Releases : Jagsonpal Pharmaceuticals Limited

Quotes and Performance

Price Extremes

Managers and Directors : Jagsonpal Pharmaceuticals Limited

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 day	-2.15%
1 week	+2.91%
Current month	+2.68%
1 month	+3.21%
3 months	+14.00%
6 months	+40.52%
Current year	+23.04%

1 week	229.54	248
1 month	217.18	263.7
Current year	155	264.5
1 year	155	264.5
3 years	109.44	328.04
5 years	49.2	328.04
10 years	6.5	328.04

Manager	Title	Age	Since
Manish Gupta CEO	Chief Executive Officer	59	16/07/2022
Nirav Niranjankumar Vora DFI	Director of Finance/CFO	-	07/10/2025
Amrut Medhekar COO	Chief Operating Officer	-	04/09/2025

Director	Title	Age	Since
Rajpal Singh Kochhar CHM	Chairman	69	04/12/2013
Harsha Raghavan CHM	Chairman	54	16/07/2022
Prithipal Singh Kochhar BRD	Director/Board Member	-	29/06/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JAGSONPAL PHARMACEUTICALS LIMITED	-2.15%	+2.91%	+1.34%	+41.94%	167M
ELI LILLY AND COMPANY	-0.49%	-4.96%	+61.09%	+113.51%	1,060B
JOHNSON & JOHNSON	-1.50%	-0.25%	+50.85%	+62.33%	651B
ABBVIE INC.	-1.83%	-1.40%	+24.08%	+75.11%	465B
ROCHE HOLDING AG	-1.17%	-2.10%	+38.61%	+40.46%	365B
NOVARTIS AG	-2.00%	-1.35%	+22.22%	+37.78%	300B
ASTRAZENECA PLC	-0.98%	+0.53%	+2.04%	+12.13%	258B
AMGEN INC.	-0.20%	+1.34%	+52.64%	+71.33%	238B
NOVO NORDISK A/S	-3.18%	-0.30%	-17.23%	-54.33%	210B
GILEAD SCIENCES, INC.	+0.08%	+3.34%	+30.12%	+92.41%	184B
Average	-1.29%	-0.08%	+26.58%	+49.27%	373.06B
Weighted average by Cap.	-1.13%	-2.15%	+38.81%	+66.36%

	2024	2025
Net sales	2.09B 21.85M 18.76M 17.56M 16.08M 30.29M 30.38M 208M 81.29M 1.05B 82.04M 80.27M 3.48B	2.69B 28.14M 24.15M 22.61M 20.7M 39M 39.11M 268M 105M 1.35B 106M 103M 4.48B
Net income	225M 2.35M 2.02M 1.89M 1.73M 3.26M 3.27M 22.38M 8.75M 113M 8.83M 8.64M 375M	554M 5.8M 4.98M 4.66M 4.27M 8.04M 8.06M 55.16M 21.56M 279M 21.76M 21.29M 923M
Net Debt	-1.39B -14.55M -12.49M -11.7M -10.71M -20.17M -20.23M -138M -54.14M -701M -54.64M -53.46M -2.32B	-1.19B -12.51M -10.74M -10.05M -9.21M -17.34M -17.39M -119M -46.54M -602M -46.97M -45.96M -1.99B